← Leaderboards
Mark Lee
Fisher Bioservices, Inc.
$5,366,155
Attributed
$5,366,155
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.7M · FY2021–24$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
Funding mix
By agency
NIH$5,366,155 · 1
By mechanism
N02$5,366,155 · 1
Top collaborators
No co-investigators on record.
Most similar at Fisher Bioservices, Inc.
Same institution · by research overlap
- Christopher Parsons$12,507,496
- Doug Smallwood$16,631,337
- Douglas Smallwood$5,820,146
- Hannah Elson$18,807,207
- Chris Parsons$2,753,688
Others in their field
Other Emerging Leaders on “Natural Products”
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Bryan Roth · Univ Of North Carolina Chapel Hill$21,325,531
Research focus
Natural ProductsRepositoryEquipment And Supply InventoriesNational Institute Of Allergy And Infectious DiseasePre-ClinicalProgramsDatabasesDrug SynthesisExtramural ActivitiesNational Cancer InstitutePharmaceutical PreparationsBiologicalPreclinical Drug EvaluationProgram EvaluationAnti-CancerChemotherapeutic AgentDevelopmental Therapeutics ProgramDivision Of Cancer Treatment And DiagnosisArchivesEvaluationFlexibilityContractorContractsResearch Personnel
Grant awards (3)
REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY EVALUATION AND DEVELOPMENT$87,236
N02 · FY2024 · CA · contact PI
REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY EVALUATION AND DEVELOPMENT$2,557,740
N02 · FY2022 · CA · contact PI
REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY EVALUATION AND DEVELOPMENT$2,721,179
N02 · FY2021 · CA · contact PI